RHPS has just mentioned the above in an e-mail, they have gone up 240% today - started at 0.60 and finished up at 1.65. Look to be quite interesting.

Drug group Sareum soars on cancer inhibitor news
Sareum, an Aim-listed drug discovery company, has more than doubled after positive results from a pre-clinical trial of its cancer treatment.
The company's Chk1 inhibitor, when combined with chemotherapeutic drugs, showed a more than two fold reduction in cancer growth rates, compared to using the chemotherapeutic alone. The cancer growth inhibitor was developed in collaboration with Cancer Research Technology and the Institute of Cancer Research. Sareum chief executive Tim Mitchell said the studies demonstrated the efficacy of its compounds in several cancer models, and trials on other models were continuing. These are still early stages - there is no licensing agreement as yet for example - but Mitchell said:
We believe the results from the recently conducted studies will significantly enhance the licensing package and assist the collaboration in selecting the best compound for development into a clinical trials candidate.
Early stage or not, the market likes the latest developments, and Sareum's shares have jumped 1.34p to 2.39p.


http://www.guardian.co.uk/business/marketforceslive/2011/mar/04/sareum-soars-cancer-inhibitor


http://www.growthcompany.co.uk/news/1607738/sareum-announce-latest-update.thtml

In the know: Capita, Sareum Holdings

* The Times
* Published: 05 March 2011
* Markets

...sector business. . Tiddler to watch Shares in Sareum Holdings more than doubled, rising 1p to 2p, after the drug discovery company said that its cancer growth inhibitor...

I think the word flat was a typo..lol some coverage today though...

MARKET REPORT by GEOFF FOSTER:

Cancer drug discovery company Sareum was flat at 2.38p after revealing that its cancer growth inhibitor therapy had shown positive results in pre-clinical trials. Apparently, when its inhibitor was combined with chemotherapeutic drugs it had led to a greater reduction in the growth rate of colon cancer than did the drugs alone.

Read more: http://www.dailymail.co.uk/money/article-1363155/MARKET-REPORT-GEOFF-FOSTER-ITV-tunes-Footsie-elite.html#ixzz1Fi3ymTMp

double post.

It could do what Provexis sp did a few years ago, next week, (soaring to 10p) or so because this is a major result by this small company !.

Certainly a good result at last for this little bioco. I held years ago but then sold as it seemed to be running out of cash. P'raps time to get back in now?

I like this post from another bb.... Opinion: Strong Buy
Price: 2.38
My Views on Sareum..in a nutshellToday 02:27

(a) It is currently oversold after spike in mid Feb and the market cap is still low at 28-32 million ...say compared to Phytopharm with a single 43% Phase 2 cure for Parkinsons and capitalised at a couple of million more

(b) The trial results are exceptional - 1 in 100 potentially successful drugs fails to get to pre-clinicals...the fallout for Phase 1-3 is statistically less and usually the pre-clinical gives a hint of failure eg 20% efficicacy..here we have a PRE CLINICAL 100% cure, see (f) for the reason why... which is the real reason for us all to stay invested

(c) Cancer cures is a potentially multibillion market

Now for the biggies

(d) despite the buzz on here probably no more than 30,000 people in a world of 7 billion are FULLY aware of the signifigance of their methodology and the outcome of the trials.. as the news spreads the investment will increase dramatically

(e) The company has no major institutional holders...with its sudden burst in size all the AIM / small cap funds need to buy some and they should by now all be tightly held by PI's who have seen 100-200% gains and haven't taken thethe profit REASON they have reached the logical conclusion that this is a multibagger like no other.... so demand will exceed supply and the price must therefore rise almost inexorably....well to the point where everyone can see the emperor is bare....this could after all be the South Sea Bubble of the 21st century!!

(e) The company is not a one trick pony..the second RNS confirms the power of the STIL platform....from the identification of a problem to tackle and the formulation of a strategy to preclinical success takes on average 6-8 years....SAR floated in late 2004 so 2011-3 is the period when the initial products will come home to roost...this is the first two of the initial products and there is a pipeline of other targets which they have started to tackle over the last 6 years which we are not including in the valuation

(f) The biggest asset the company has is the technology to identify the disease cause and the molecule to solve it...this can be rolled out for hundreds of diseases....the building of the magic bullet and the testing of it are time consuming but relatively simple....so in effect YOU ARE NOT investing in a cure for myeloid luekemia but rather in a cloud factory to produce the CURES to many diseases.....and healthcare is the only part of the economy in the UK or the world which is not being cut back at the moment

IN SUMMARY SAREUM's DIAGNOSIS AND DESIGN PROCEDURE IS BIGGER THAN E-PROCUREMENT / RDIF / ALTERNATIVE ENERGY and SCARCE MINERAL RESOURCES PUT TOGETHER.

DYOR

Going by this : 5 to 10p next week ?....I'd like to think so, but surely a rise by a penny is in the running on monday .....hope so...

Is Tabby in these? We are sunk if he is! ;o)

Nah! Only joking Tabs! :0)

SAR has a very good chance of strong interest from potential licencees now. Nothing guaranteed as always with research companies like this, but it cannot be ruled out as a potential 10+ bagger from here on.

required field

This could go anywhere but I would keep my finger over the sell button If I were you, This is being ramped by day traders, keep in mind SAR has a bigger M/Cap than ASM who have 23m in cash and five products on the go not holding either by the way just an observation.

A bit of a sob story for you Driver. I have been in these for longer than i care to remember. On Feb 9th the sp flew and I decided to sell a majority of my holding for 4.6p having bought substantially lower; pressed sell and sat back with a satisfied grin, at which there was a flash and a bang and the electric cut off. By the time the power had been restored the sp had fallen to 3.1p and my sell order had failed! Sold at that price, without a grin! Still holding 150k. Not a lot but staying with the potential. (Ramped or otherwise!)

kim
LOL Stick with it, Good Luck

Kim.I am Mr. luckyyou should know thathad my best year ever last yearand this year has started the same.
First of all let me thank 3 monkies for putting this dog back on my radarthank you!...
10 years back I was invested in millennium pharmaceuticals on the nasdaqI dont even know if they are still going?...around 2003 they pulled out of the UK and SER were spun outI yhink?...those with better knowledge can correct mewhat a bad stockbegged, borrowed, gifted moneydownsized operations.you name it investors covered it
Then on the 07/02/11 we had the positive results from leukaemia studythey looked good and made a few of us take noticesome paid over 4ptoo bigger risk for me
After tgree big daysthe price kept dropping..why?
Kim when the SP flunked to 1.30p on no other newsI thought it was fcuking mentaland took a punt
Within a few days down to 1-05pI thought I was fcuking mentalthen came the second bit of good news Dr Tim Mitchell, commented: "These are exciting advances, demonstrating efficacy of our Chk1 compounds in several cancer models. Studies on additional models are on-going.
I dont believe in coincidencesthis works in two types of cancer.fact!!!
Kimwith me investedyou should feel lucky.I have spoken to a guy today that assists in my luckhe reckons it will hit 4p tomorrow at some stageenjoy the ride!

Thanks for giving me an acknowledgement tabasco - will try and buy some more early tomorrow to get my initial awful price down which the delightful Halifax made me pay. Very hard to trade last Friday - would not let me execute a trade again and I certainly wasn't leaving it up to them again!!!!! Good luck all and if I make a profit on this I shall certainly donate some of it to Cancer Research. Don't know now whether I should have got out of PYC.

I hope you all turn out winners. Oh, and me too!

It's what I suspected : going ballistic....

morning all - another good day - plenty of press over the weekend & from the other side:

'I sent another email to Claire Noyce of Hybridan. My Email: Hi Claire, Thanks for your reply, but Tim put me onto yourselves! Can you at least let me know how often brokers target prices are reviewed as Sareum is now well out of date? Kind Regards xxxxx

Claire's reply last night: Dear xxxxx, Again, it is very difficult for me to comment in detail. To keep this non stock specific, i would make two comments. One: there is no rule here defining when a broker needs to move his target and two:Companies don't always want research written for various reasons it might not be the right time. Best regards Claire Noyce

I read this as Sareum asking Hybridan not to report yet and probably because they want the latest RNS to run its course and also they are very close to a deal, which will then make it easier to re-rate the stock! GLA today'

onwards & upwards!!

3 monkies

Did you buy more.

Oh! yes, brought my spread down to 3.20 thought I had waited long enough for them to drop after the rise .......... guess what - didn't wait long enough, but that is typical of me but if there is good news to come I am sure it will come right. Hey ho!

I had my finger hovering over the sell button at 3.1p when L2 was indicating that the sp was going to go ar*e up but did nothing, should have sold and bought back at 2p but there you go. Didn't do it! A bit premature to sell though; if licencees are not forthcoming in the next couple of months then maybe there is a rough ride for SAR ahead. Can't see it at the moment though, these rose tinted specs are pretty strong! :o)